Sempra
84.06USD
-0.7100 (-0.84%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SRE.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.21▲ | $1 | 1 | 1 |
| Next quarter | $1.25▼ | $1.55 | 0 | 2 |
| Current year | $5.13▲ | $5.11 | 2 | 1 |
| Next year | $5.54▲ | $5.54 | 2 | 2 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.06 | $1.16 | +0.10 (+9.6%) |
| 2026-03-31 | $1.51 | $1.51 | -0.00 (-0.3%) |
| 2025-12-31 | $1.17 | $1.28 | +0.11 (+9.2%) |
| 2025-09-30 | $0.91 | $1.11 | +0.20 (+21.7%) |
286 ratings from 26 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| HSBC | Initiated | Buy | $97.5 | Oct 22, 2026 |
| Truist Securities | Maintained | Buy | $96 $94 | Oct 14, 2026 |
| Barclays | Maintained | Overweight | $103 $90 | Oct 12, 2026 |
| JP Morgan | Maintained | Overweight | $102 $99 | Oct 12, 2026 |
| Scotiabank | Initiated | Sector Perform | $83 | Sep 29, 2026 |
| Morgan Stanley | Maintained | Overweight | $104 $100 | Sep 18, 2026 |
| Truist Securities | Maintained | Buy | $100 $96 | Sep 3, 2026 |
| JP Morgan | Maintained | Overweight | $113 $102 | Sep 2, 2026 |
| Jefferies | Upgraded from Hold | Buy | $101 $97 | Sep 1, 2026 |
| Mizuho | Downgraded from Outperform | Neutral | $104 $84 | Aug 31, 2026 |
| Morgan Stanley | Maintained | Overweight | $108 $104 | Aug 21, 2026 |
| Truist Securities | Maintained | Buy | $107 $100 | Aug 13, 2026 |
| BMO Capital | Maintained | Outperform | $103 $102 | Jul 22, 2026 |
| Barclays | Maintained | Overweight | $105 $103 | Jul 9, 2026 |
| TD Cowen | Initiated | Buy | — | Jul 8, 2026 |
| Truist Securities | Maintained | Buy | $108 $104 | May 18, 2026 |
| BMO Capital | Maintained | Outperform | $105 $103 | May 11, 2026 |
| Morgan Stanley | Maintained | Overweight | $105 $104 | Apr 21, 2026 |
| Truist Securities | Initiated | Buy | $108 | Apr 21, 2026 |
| Barclays | Maintained | Overweight | $95 $105 | Apr 15, 2026 |
| Wells Fargo | Maintained | Overweight | $113 $115 | Mar 23, 2026 |
| JP Morgan | Maintained | Overweight | $98 $106 | Mar 18, 2026 |
| UBS | Maintained | Neutral | $96 $100 | Mar 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $105 $107 | Mar 5, 2026 |
| Argus Research | Upgraded from Hold | Buy | — | Mar 4, 2026 |
76 filings from 23 insiders · 4 buy / 3 sell over 6m
Officers and directors of SRE, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Weaving AnyaDirector | GrantPhantom Shares | 160.15 | $78.05 | $12k | Oct 1, 2026 |
| Sagara Kevin C.Director | GrantPhantom Shares | 160.15 | $78.05 | $12k | Oct 1, 2026 |
| CONESA ANDRESDirector | GrantPhantom Shares | 160.15 | $78.05 | $12k | Oct 1, 2026 |
| Kirk Jennifer MDirector | GrantPhantom Shares | 160.15 | $78.05 | $12k | Oct 1, 2026 |
| Ferrero PabloDirector | GrantPhantom Shares | 160.15 | $78.05 | $12k | Oct 1, 2026 |
| Taylor Jack TDirector | GrantPhantom Shares | 160.15 | $78.05 | $12k | Oct 1, 2026 |
| WARNER CYNTHIA JDirector | GrantPhantom Shares | 371.56 | $78.05 | $29k | Oct 1, 2026 |
| YARDLEY JAMES CDirector | GrantPhantom Shares | 160.15 | $78.05 | $12k | Oct 1, 2026 |
| MARK RICHARD JDirector | GrantPhantom Shares | 160.15 | $78.05 | $12k | Oct 1, 2026 |
| MEARS MICHAEL NDirector | GrantPhantom Shares | 160.15 | $78.05 | $12k | Oct 1, 2026 |
| WINN CAROLINE ANNOfficer | Sell | 8.0k | $89.85 | $724k | Jun 17, 2026 |
| FERRERO PABLO ADirector | Sell | 2.6k | $89.53 | $233k | May 18, 2026 |
| DAY DIANA LOfficer | Sell | 3.3k | $92.13 | $304k | May 14, 2026 |
| WEAVING ANYADirector | Grant | 1.5k | — | — | May 12, 2026 |
| FERRERO PABLO ADirector | Grant | 1.5k | — | — | May 12, 2026 |
| CONESA ANDRESDirector | Grant | 1.5k | — | — | May 12, 2026 |
| MARK RICHARD JDirector | Grant | 1.5k | — | — | May 12, 2026 |
| BIRD JUSTIN CHRISTOPHEROfficer | Sell | 1.1k | $96.69 | $109k | Apr 1, 2026 |
| WOLD DYAN Z.Officer | Sell | 1.5k | $95.38 | $147k | Mar 16, 2026 |
| KIRK JENNIFER MDirector | Buy | 1.0k | $93.44 | $93k | Mar 12, 2026 |
No analyst notes on SRE yet.
Analyst Ratings
19 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 13 | 5 | 0 | 0 | Buy2.10 |
| 1 mo ago | 4 | 12 | 4 | 0 | 0 | Buy2.00 |
| 2 mo ago | 3 | 11 | 5 | 0 | 0 | Buy2.11 |
| 3 mo ago | 3 | 12 | 5 | 0 | 0 | Buy2.10 |
Members whose judged calls on SRE have played out most reliably.
No settled calls on SRE yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice